BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25943877)

  • 1. Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids.
    Southam AD; Khanim FL; Hayden RE; Constantinou JK; Koczula KM; Michell RH; Viant MR; Drayson MT; Bunce CM
    Cancer Res; 2015 Jun; 75(12):2530-40. PubMed ID: 25943877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
    Dillon R; Greig MJ; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells.
    Iwai T; Kume S; Chin-Kanasaki M; Kuwagata S; Araki H; Takeda N; Sugaya T; Uzu T; Maegawa H; Araki SI
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of stearoyl-CoA desaturase-1 in differentiating 3T3-L1 preadipocytes upregulates elongase 6 and downregulates genes affecting triacylglycerol synthesis.
    Ralston JC; Badoud F; Cattrysse B; McNicholas PD; Mutch DM
    Int J Obes (Lond); 2014 Nov; 38(11):1449-56. PubMed ID: 24566853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
    Kim E; Lee JH; Ntambi JM; Hyun CK
    Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCD1 inhibition during 3T3-L1 adipocyte differentiation remodels triacylglycerol, diacylglycerol and phospholipid fatty acid composition.
    Ralston JC; Mutch DM
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():29-37. PubMed ID: 25959085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism.
    Stamatikos AD; Paton CM
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E767-75. PubMed ID: 23941875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scd1 mammary-specific vector constructed and overexpressed in goat fibroblast cells resulting in an increase of palmitoleic acid and oleic acid.
    Wang L; You J; Zhong B; Ren C; Zhang Y; Li M; Zhang G; Jia R; Ying S; Wang F
    Biochem Biophys Res Commun; 2014 Jan; 443(2):389-94. PubMed ID: 24309099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
    Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
    Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action.
    Zhang J; Kris-Etherton PM; Thompson JT; Hannon DB; Gillies PJ; Heuvel JP
    J Nutr Biochem; 2012 Apr; 23(4):400-9. PubMed ID: 21658928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids.
    Mason P; Liang B; Li L; Fremgen T; Murphy E; Quinn A; Madden SL; Biemann HP; Wang B; Cohen A; Komarnitsky S; Jancsics K; Hirth B; Cooper CG; Lee E; Wilson S; Krumbholz R; Schmid S; Xiang Y; Booker M; Lillie J; Carter K
    PLoS One; 2012; 7(3):e33823. PubMed ID: 22457791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells.
    Choi Y; Park Y; Pariza MW; Ntambi JM
    Biochem Biophys Res Commun; 2001 Jun; 284(3):689-93. PubMed ID: 11396956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short- and long-chain fatty acids on the expression of stearoyl-CoA desaturase and other lipogenic genes in bovine mammary epithelial cells.
    Jacobs AA; Dijkstra J; Liesman JS; Vandehaar MJ; Lock AL; van Vuuren AM; Hendriks WH; van Baal J
    Animal; 2013 Sep; 7(9):1508-16. PubMed ID: 23597233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
    Scaglia N; Igal RA
    Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
    Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
    Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
    Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
    Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
    Dobrzyń A; Dobrzyń P
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer.
    Lombardi S; Goldman AR; Tang HY; Kossenkov AV; Liu H; Zhou W; Herlyn M; Lin J; Zhang R
    Cancer Res Commun; 2023 Jun; 3(6):1067-1077. PubMed ID: 37377614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.